Principles of Tissue Engineering

by Robert Lanza (Editor), Robert S. Langer (Editor), Joseph Vacanti (Editor)

Tissue engineering is a rapidly growing area of biomedical research with obvious commercial applications. This is a comprehensive, definitive text-reference which will become the benchmark in this area. Principles in Tissue Engineering strikes a balance among the diversity of subjects that are related to tissue engineering, including biology, chemistry, material science, engineering, immunology, and transplantation, while emphasizing those research areas that are likely to be of the most value to medicine in the future.

This book represents the combined intellect of almost 100 scholars and clinicians who's pioneering work has been instrumental to ushering in this fascinating and important field.


Key Features

* Coverage is comprehensive yet succinct
* Emphasizes research areas that are likely to be of the most value to medicine in the future
* Topics covered include biology, chemistry, material science, engineering, immunology, and transplantation aspects of tissue engineering

808 pages, Hardcover

First published January 1, 1997

About the author

ROBERT LANZA, MD, is one of the most respected scientists in the world. He is head of Astellas Global Regenerative Medicine, Chief Scientific Officer of the Astellas Institute for Regenerative Medicine, and adjunct professor at Wake Forest School of Medicine. TIME magazine recognized him as one of the “100 Most Influential People in the World,” and Prospect magazine named him one of the Top 50 “World Thinkers” in 2015. He is credited with several hundred publications and inventions, and more than 30 scientific books, including the definitive references in the field of stem cells and regenerative medicine. A former Fulbright Scholar, he studied with polio pioneer Jonas Salk and Nobel Laureates Gerald Edelman and Rodney Porter. Lanza was part of the team that cloned the world’s first human embryo, as well as the first to successfully generate stem cells from adults using somatic-cell nuclear transfer (therapeutic cloning).